Fig. 5.

Schematic illustration of the structure of sHDL nanodiscs and the lymph node targeting pathway of antigens and adjuvants-loaded sHDL nanodiscs, resulting in robust anti-tumor therapeutic efficacy with the elicitation of robust antigen-specific CD8α + cytotoxic T-lymphocyte responses. Reproduced with permission from Ref. [79].